title: Bending the rule of monotherapy for migraine prevention?
authors.affiliation: Service of Neurology, University Hospital, Marques de Valdecilla, Santander 39008, Spain.
authors.forename: Randolph W
authors.initials: RW
authors.lastname: Evans
authors.forename: Julio
authors.initials: J
authors.lastname: Pascual
authors.forename: Miguel J A
authors.initials: MJ
authors.lastname: Láinez
authors.forename: Rogelio
authors.initials: R
authors.lastname: Leira
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000517:prevention & control*; D011433:Propranolol / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D000639:Amitriptyline; D014635:Valproic Acid; D011433:Propranolol